
The Institut Guttmann is an international centre of reference in neurorehabilitation, specialising in the medical and surgical treatment and comprehensive rehabilitation of adults, young people and children with spinal cord injury, acquired brain injury or other neurological disabilities.
Its objective is to provide specialised, comprehensive, intensive, continuous and personalised care, based on scientific evidence and with the highest levels of compassion, science and technology.
Access information on the Neurorehabilitation Hospital at this link.
Neurorehabilitation team
The neurorehabilitation team at the Institut Guttmann is the soul of the hospital, working together on a daily basis to offer the best specialised and personalised care to every patient. Go to the website to get to know us!


We would like to highlight some milestones for 2023, in which we have taken another step forward as a high specialty hospital and centre of reference:
The Bariatric Surgery Program for patients with spinal cord injury and morbid obesity has been consolidated
Together with the Germans Trias i Pujol University Hospital, this is a unique and pioneering program in Spain for highly complex patients applying robotic technology to people who until now were not offered any possibility . The program has already been successfully implemented with 9 interventions.
The Germans Trias i Pujol Hospital and the Institut Guttmann started this collaboration in 2022 to provide solutions to those people with morbid obesity and a spinal cord injury.
3D technology in surgical interventions for osteomas
We have continued to apply 3D technology in the surgical interventions of osteomas that grow around the joints in neurological patients, blocking them and causing severe limitations in mobility, functionality and quality of life. This technique facilitates surgical planning and improves the execution of the surgery, with the consequent reduction of risks.
We are consolidating ourselves as a center of high expertise in the treatment of spinal cord patients with nerve transposition surgery of the quadriplegic hand.
This surgery allows, in patients with injuries of a high neurological level, to transfer a preserved nerve to an area below the spinal cord injury and to be able to gradually recover the mobility of the hand. This intervention, together with tendinous transposition in quadriplegic patients, adds complexity to our portfolio of services and, above all, brings remarkable value in terms of health by contributing to an improvement in the functionality of these people. Last October, a group of surgeons from the Toledo National Hospital for Paraplegics attended one of these interventions at our hospital to learn the technique of our team of NeuroTraumatologists.
We have launched the first randomized multicenter study with the Eksoeskeleton AtalanteX from the company Wandercraft.
The difference with other exoskeletons is that, in this case, the study is aimed at people who have suffered unictus and have walking problems and aims to show that it is effective in improving walking in patients with severe walking problems, including with upper limb problems or cognitive problems. The Institut Guttmann was the first hospital to launch it, for a total of 9 patients.
Hospital activity
Regarding the assistance activity, during the year 2023 a total of 5,065 people have been treated.Of these, 1,002 were for the first time. In addition, 801 patients have been admitted and the functional children’s rehabilitation unit has attended to 261 minors up to 16 years of age.
Since the Guttmann Barcelona center was launched in 2019, part of the Neurorehabilitation Hospital’s activity has been treated in this center. For comparative purposes, it should be added to that in below, the activity contained in the Guttmann Barcelona section is detailed.
| 2023 ACTIVITY | ||
| PATIENTS SEEN | 5.065 | |
| Catalonia | 4.795 | 94,67% |
| Other autonomous communities | 207 | 4,09% |
| Overseas | 88 | 1,74% |
| PATIENTS HOSPITALISED | 801 | |
| Catalonia | 598 | 74,66% |
| Other autonomous communities | 138 | 17,23% |
| Overseas | 65 | 8,11% |
| PATIENTS SEEN FOR THE FIRST TIME | |||||
| 2019 | 2020 | 2021 | 2022 | 2023 | |
| Total new patients | 1.064 | 973 | 1.139 | 1.039 | 1.002 |
| By type of injury | |||||
| Spinal cord injury | 230 | 178 | 234 | 254 | 236 |
| Adquired brain damage | 580 | 524 | 501 | 475 | 548 |
| Others (GB, PRN, dystrophies, myopathies, progressives, post-polio, others) | 254 | 271 | 404 | 310 | 218 |
The distribution by age and sex of the patients treated during 2023 was as follows:
| PATIENTS BY AGE AND GENDER | ||||
| Patients | Women/Girls | Men/Boys | Both | % |
| From 0 to 16 y/o | 122 | 187 | 309 | 6,10% |
| From 17 to 30 y/o | 151 | 263 | 414 | 8,17% |
| From 31 to 45 y/o | 349 | 599 | 948 | 18,72% |
| From 46 to 60 y/o | 658 | 1.138 | 1.796 | 35,46% |
| From 60 y/o | 636 | 962 | 1.598 | 31,55% |
| Total | 1.916 | 3.149 | 5.065 | |
| % | 37,83% | 62,17% |
